Nostos Genomics Patents

Patent portfolio assigned to Nostos Genomics (verified via public assignee records). Berlin, Germany (founded 2018); AION AI-driven variant-interpretation platform for rare-disease diagnostics. Acquired by Limbus (Sep 2025). Per GenomeWeb, the firm has applied for a US patent on the transparency component of its tech (company-held; count not visible). Partner: Genomenon (technology integration). Competitors in AI variant interpretation: Emedgene/Illumina, Genoox/Franklin, Fabric Genomics, Diploid, 3billion.